Muna Therapeutics

Muna Therapeutics company information, Employees & Contact Information

Muna Therapeutics is a privately held biopharmaceutical company founded in 2020 and based in Copenhagen, Denmark. Muna discovers and develops therapies that slow or stop devastating neurodegenerative diseases including Alzheimer’s, Frontotemporal Dementia and Parkinson’s. These disorders impact memory, movement, language, behavior and personality resulting in disability and death of millions of patients around the globe. We focus our groundbreaking science on identifying new medicines to preserve cognition and other brain functions and enhance resilience to neurodegenerative diseases. Our name reflects this focus: Muna means ‘to remember’ in Old Norse.

Company Details

Employees
56
Founded
-
Address
Nordre Fasanvej 215, Copenhagen (Frederiksberg),capital Region Of Denmark 2000,denmark
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Copenhagen (Frederiksberg), Capital Region of Denmark
Looking for a particular Muna Therapeutics employee's phone or email?

Muna Therapeutics Questions

News

Muna Therapeutics Announces Strategic Alliance with GSK to Accelerate Development of Novel Treatments for Alzheimer's Disease - PR Newswire

Muna Therapeutics Announces Strategic Alliance with GSK to Accelerate Development of Novel Treatments for Alzheimer's Disease PR Newswire

Muna Therapeutics presents new TREM2 agonists - BioWorld MedTech

Muna Therapeutics presents new TREM2 agonists BioWorld MedTech

Muna Therapeutics identifies new Kv1.3 channel blockers - BioWorld MedTech

Muna Therapeutics identifies new Kv1.3 channel blockers BioWorld MedTech

Muna Therapeutics ahead of new funding round: "A conference like this is an opportunity" - medwatch.com

Muna Therapeutics ahead of new funding round: "A conference like this is an opportunity" medwatch.com

GSK inks 2nd neuro pact in weeks, this time with Danish biotech Muna in Alzheimer's - Fierce Biotech

GSK inks 2nd neuro pact in weeks, this time with Danish biotech Muna in Alzheimer's Fierce Biotech

Muna Therapeutics Raises $73 Million to Advance Neurodegenerative Disease Focus - BioSpace

Muna Therapeutics Raises $73 Million to Advance Neurodegenerative Disease Focus BioSpace

Michael J Fox Foundation awards $4.9m grant to Muna Therapeutics - PMLiVE

Michael J Fox Foundation awards $4.9m grant to Muna Therapeutics PMLiVE

Muna Therapeutics launches: UK DRI Director will Chair the - UK DRI

Muna Therapeutics launches: UK DRI Director will Chair the UK DRI

GSK will complete new Alzheimer's project with Muna Therapeutics within five years after "massive infusion" - medwatch.com

GSK will complete new Alzheimer's project with Muna Therapeutics within five years after "massive infusion" medwatch.com

Muna raises $73M to go after Alzheimer's, Parkinson's and MS - Fierce Biotech

Muna raises $73M to go after Alzheimer's, Parkinson's and MS Fierce Biotech

TREM2 agonists revealed in Muna Therapeutics patent - BioWorld MedTech

TREM2 agonists revealed in Muna Therapeutics patent BioWorld MedTech

Top Muna Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant